The federal government’s anti-drug efforts are inefficient and ineffective, according to a just released report issued by the Congressional watchdog agency, the US Government Accountability Office (GAO).
As if we didn’t know.
The GAO report assessed whether the Obama administration’s anti-drug strategies, as articulated by the White House Office of National Drug Control Policy (the ONDCP aka the Drug Czar’s office) in its 2010 National Drug Control Strategy report, have yet to achieve its stated goals.
The answer? They haven’t.
States the GAO:
“The public health, social, and economic consequences of illicit drug use, coupled with the constrained fiscal environment of recent years, highlight the need to ensure that federal programs efficiently and effectively use their resources to address this problem. ONDCP has developed a 5-year Strategy to reduce illicit drug use and its consequences, but our analysis shows lack of progress toward achieving four of the Strategy’s five goals for which primary data are available.”
In particular, the GAO criticized the administration for failing to adequately address rising levels of youth marijuana consumption. The GAO also rebuffed the ONDCP’s allegation that increased rates adolescent marijuana use are a result of the passage of statewide laws decriminalizing the plant or allowing for its therapeutic use.
“Other factors, including state laws and changing attitudes and social norms regarding drugs, may also affect drug use. We examined studies on three of these other factors, which we refer to as societal factors, which may affect youth marijuana use. … The studies that assessed the effect of medical marijuana laws that met our review criteria found mixed results on effects of the laws on youth marijuana use. … [S]tudies that assessed the effect of marijuana decriminalization that met our review criteria found little to no effect of the laws on youth marijuana use.”
You can read the full GAO report here.
The National Organization for the Reform of Marijuana Laws is pleased to announce that it is now providing educational content to the editors of The Answer Page, Inc. The Answer Page, Inc. is an online medical educational resource founded in 1998 that provides daily education to healthcare professionals in 120 countries. TheAnswerPage (online at TheAnswerPage.com) uses the Socratic question-and-answer teaching method. The content for the website is primarily written by academic clinicians respected in their fields. All content is peer-reviewed and referenced from current texts and recent literature.
TheAnswerPage now features educational content in the area of medical marijuana. The editorial team of TheAnswerPage states: “Medical marijuana may be controversial, but it is now an important area of study in healthcare. Doctors and healthcare professionals must understand the medical, legal, social and political issues to best respond to their patients’ questions and attend to their needs.”
The medical marijuana ‘lecture series’ begins with an introductory primer to the cannabis plant. The following week focuses on five distinct cannabinoids and their therapeutic potential.
“NORML recognizes that physicians and health care professionals desire balanced information regarding the safety and efficacy of cannabis as a potential therapy,” NORML’s Deputy Director Paul Armentano said. “NORML is pleased to provide its expertise to TheAnswerPage to assist health care professionals better understand and navigate this important public health issue.”
Subscribers to TheAnswerPage receive continuing medical education (CME) credit by reading the content and completing an industry-unique Interactive Crossword Puzzle. The clues are structured to reinforce the educational material, and links are provided to the related content. Subscribers have personal educational accounts that organize their earned CME credit and allow clinicians to download, email or print CME certificates for credentialing and licensing.
TheAnswerPage.com has over 50 interactive crossword puzzles posted, for earning CME credit. New content and crosswords are posted daily.
TheAnswerPage‘s medical cannabis content is available at the ‘syllabus;’ select the pull down menu option: “Medical Marijuana — Medical, Legal, Social, and political Issues.” Free registration to the site is required.
I was on a radio show this past weekend debating a prohibitionist who still believes that medical cannabis is little more than a hoax…a ‘camel’s nose under the tent’ to trick the American public into legalizing cannabis for recreational purposes. I’ve heard this individual exclaim numerous times over the years that he would not give cannabis to a loved one who needed it, because, he still clings to the myth that cannabis in its natural form is a ‘dangerous narcotic’…he even claims cannabis is toxic to humans (despite the drug having a lethal dose rating of fifty…the safest indicator measurement of a drug’s lack of toxicity).
Someone who was listening to the show but could not get on the air to address the prohibitionist’s anti-pot prevarications forwarded me an email and link to a recent CNN video of a young boy in Oregon lawfully using medical cannabis for his autism. Now this is not the first time NORML’s seen credible information about how cannabis can help children with autism, to wit:
In 2009 Brown University writing instructor Marie Myung-Ok Lee’s essay on her successfully treating her autistic son J. with cannabis broke this new ground for parents trying to raise children during both the era of cannabis prohibition and the re-discovery of cannabis as a valuable, affordable, safe and non-toxic medicine.
In fact, Marie’s frank and daring essay about children, autism and cannabis has spawned numerous other related articles, TV interviews and videos. Many of them archived by NORML here.
The KMVT video below will be added to this growing archive…it is hard to watch, it made me cry thinking about 1) how truly difficult life must be for Alexander Echols, 2) how enduring and loving his parents are, 3) how ignorant (and at times extreme) prohibitionists are in trying to ban all human interface with the quite wonderful cannabis plant and 4) how blessed we are as humans to know of and have a relationship with this remarkable plant species.
Whether one has an evolutionary or ‘intelligent design’ point of view regarding the origins of life, the relationship between cannabis and humans is an indisputably ancient one, and for many humans today a genuine ‘quality of life’ issue that is not at all served well under a prohibition regime.
One of the major public policy and business fronts to end cannabis prohibition in America is to pressure the federal government to allow American farmers the same ability to cultivate industrial hemp like farmers in the United Kingdom, France, Russia and even Canada do under current so-called anti-drug international treaties. Ninety percent of hemp used in the United States is cultivated and imported from Canada.
What sane reason can be employed by the federal government to ban industrial hemp cultivation when Canadian farmers can prosper from cultivating it?
Numerous states–just like with decriminalization, medicalization and legalization–have passed industrial hemp reform laws that run afoul of the federal government’s anti-cannabis policies. This has created upward political pressure on Congress to introduce needed hemp law reform.
Check out this recent Washington Post article profiling lobbying efforts to get hemp legalized.
You can help out by signing the White House petition to bring the matter of industrial hemp law reform before the Obama Administration for a public reply.
See the dozen or so state hemp laws here.
To learn more about hemp and law reform efforts in states and Congress check out VoteHemp.
The imposition of so-called per se drugged driving laws, which create new traffic safety violations for drivers who operate a vehicle with the presence of trace amounts of certain controlled substances and/or their inert metabolites (byproducts) in their blood or urine, do not reduce incidences of traffic safety deaths.
That’s the conclusion of a just-published study by economists at the University of Colorado, Denver and Montana State University. The study is available from the Institute for the Study of Labor (IZA) in Germany as a Discussion Paper.
Since 1990, 11 states have passed so-called zero-tolerant per se drugged driving laws which make it illegal for one to drive with detectable levels of a controlled substance in his or her system. Five additional states have passed similar laws specifying non-zero limits for controlled substances or their metabolites. Fourteen (Arizona, Delaware, Georgia, Illinois, Indiana, Iowa, Michigan, Nevada, Ohio, Pennsylvania, Rhode Island, Utah, Washington, and Wisconsin) of these sixteen states impose these strict liability per se standards for cannabis. Recently, the White House Office of National Drug Control has recommended zero tolerant per se drug standards for all US states.
Using state-level data from the Fatality Analysis Reporting System (FARS) for the period 1990-2010, authors examined the relationship between the adoption of controlled substance per se thresholds and overall incidences of traffic fatalities. They found that the relationship is statistically indistinguishable from zero and concluded that there is no evidence that these limits reduced traffic deaths.
Authors reported: “Despite the fact that these laws have been touted by politicians and academics as an effective strategy for making our roadways safer, we find no evidence that they reduce traffic fatalities. … [W]e cannot determine why per se drugged driving laws do not work, and leave this issue to future researchers. However, our results clearly indicate that, as currently implemented, laws that make it illegal to drive with detectable levels of a controlled substance in the system have little to no effect on traffic fatalities.”
In November, Washington state voters approved Initiative 502, which legalizes the private use and retail sale of cannabis to adults, but also imposes a 5ng/ml THC/blood per se limit for drivers over the age of 21. In Colorado, where voters on Election Day similarly legalized cannabis, Democrat Gov. John Hickenlooper and Republican Senator Steven King are calling for the passage of nearly identical per se cannabis legislation.
NORML has consistently opposed the imposition of stand-alone per se limits for cannabinoids, arguing that the presence of THC in blood, particularly at lower levels, is an inconsistent predictor of behavioral impairment, particularly in more frequent consumers who may potentially test positive for trace, residual THC levels in their blood for periods of time exceeding any period of acute impairment.
Operation of a motor vehicle while under the influence of cannabis is already a criminal offense in all 50 states. However, in order for one to gain a criminal conviction under most state DUI laws, prosecutors must prove that a motorist recently ingested cannabis and that doing so prohibited him or her from driving safely.
Full text of the study, “Per Se Drugged Driving Laws and Traffic Fatalities,” is available online here. A separate paper previously published by the same authors reported that the passage of statewide medical marijuana laws is associated with decreased incidences of traffic fatalities.